Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company TRB Chemedica International S.A.
DescriptionAnthraquinone derivative
Molecular Target Interleukin-1 (IL-1)
Mechanism of ActionInterleukin-1 (IL-1) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPain
Indication DetailsTreat osteoarthritis (OA) pain and functional discomfort
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today